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responsibility of XAbstract A simple and selective micellar electrokinetic chromatographic (MEKC) method has been
developed for the analysis of ﬁve pharmaceutical binary mixtures containing three non-steroidal anti-
inﬂammatory drugs (NSAIDs). The investigated mixtures were Ibuprofen (IP)–Paracetamol (PC),
Ibuprofen (IP)–Chlorzoxazone (CZ), Ibuprofen (IP)–Methocarbamol (MC), Ketoprofen (KP)–
Chlorzoxazone (CZ) and Diclofenac sodium (DS)–Lidocaine hydrochloride (LC). The separation
was run for all mixtures using borate buffer (20 mM, pH 9) containing 15% (v/v) methanol and
100 mM sodium dodecyl sulphate (SDS) at 15 kV and the components were detected at 214 nm.
Different factors affecting the electrophoretic mobility of the seven investigated drugs were studied
and optimized. The method was validated according to international conference of harmonization
(ICH) guidelines and United States pharmacopoeia (USP). The method was applied to the analysis of
ﬁve pharmaceutical binary mixtures in their dosage forms. The results were compared with other
reported high performance liquid chromatographic methods and no signiﬁcant differences were
observed.
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i’an Jiaotong University.1. Introduction
Non-steroidal anti-inﬂammatory drugs (NSAIDs) are widely
used as analgesics and at higher doses, as anti-inﬂammatory in
the treatment of rheumatic diseases and other musculoskeletal
disorders. They are also available as over-the counter pharma-
ceutical preparations. The safety and efﬁcacy of these drugs are
critically related to whether or not their contents conform tolsevier B.V. All rights reserved.
M.E. El-Kommos et al.54labeled amounts [1,2]. They are introduced all over the world in
many pharmaceutical formulations either alone or with adjuvant
drugs whether to synergize, or to impart added effect.
So, an urgent need arises for the development of analytical
methods for their determination in their pharmaceutical
mixtures. Five commonly prescribed pharmaceutical binary
mixtures containing three NSAIDs were selected for our
analytical study. Literature survey revealed that these selected
binary mixtures were analyzed by high performance liquid
chromatography (HPLC) [3–11] in addition to UV-chemo-
metric assisted spectrophotometric methods [12–14]. Capillary
electrophoresis (CE) has been used for the determination of
NSAIDs [2,15–19]. However, the analysis of binary mixtures
of these drugs with muscle relaxants, local anesthetics and
analgesics by CE was not found in the literature. Micellar
electrokinetic chromatography (MEKC) is a hybrid of elec-
trophoresis and chromatography introduced by terabe in
1984. MEKC is one of the most widely used CE modes.
MEKC is characterized by that it can be used for the
separation of neutral solutes as well as charged ones. The
separation of neutral species is accomplished by the use of
surfactant in the running buffer in concentration above the
critical micelle concentration. The neutral solutes arranged
themselves in and out of the micelles and move according to
the micelle velocity not by their electrophoretic mobility
resulting in good separation of the mixture [20].
The chemical structures of the drugs contained in the
investigated binary mixtures are shown in Fig. 1. In the
present work, a very simple MEKC technique was applied
for the ﬁrst time for the separation and simultaneous determi-
nation of seven drugs in a synthetic mixture and then applied
to the determination of the drugs in ﬁve pharmaceutical binary
mixtures. The studied drugs are three NSAIDs either with
anesthetic, analgesic antipyretic or skeletal muscle relaxants or
other analgesics. The investigated mixtures were IP–PC, IP–
CZ, IP–MC, KP–CZ and DS–LC. The literature survey
revealed that there is no reported CE method in the literatureFig. 1 Structures of thfor the separation and simultaneous determination of the
investigated binary mixtures. The aim of the present work was
to develop an MEKC method for the analysis of the active
constituents of these commercially available mixtures under
the same conditions and to offer the possibility of analyzing
possible future binary mixtures containing NSAIDs with
skeletal muscle relaxants, analgesic, or local anesthetic.2. Experimental
2.1. Apparatus and electrophoretic conditions
A CE system (G 1600A model, Agilent technologies,
Waldbronn, Germany) with UV diode-array detector (DAD)
was used. It consists of fused silica (Polymicro Technologies,
Phoenix, AZ, USA) of 65 cm total length with 50 mm internal
diameter. The capillary temperature was set at 25 1C. The
separation was performed using borate buffer (20 mM, pH 9)
containing 15% (v/v) methanol and 100 mM SDS. The
running buffer was ﬁltered through 0.45 mm pore size mem-
brane ﬁlter of 30 mm in diameter. Hydrodynamic injection of
the sample vial was applied with the aid of pressure mode for
10 S at 50 mbar. Diode-array detector was set at 214 nm.
Before start-up, the capillary was preconditioned with varying
concentrations of NaOH on different periods of time at room
temprature and ﬁnally with running buffer in order to activate
the interior wall of the capillary. Between runs the capillary
was rinsed with running buffer for 5 min. Ultrasonic cleaner
(Cole-Parmer, Chicago, USA), pH meter, model 3305 (Jen-
way, London, UK) and sartorius handy balance—H51 (Han-
over, Germany) were used throughout the experiments.
2.2. Materials and reagents
Pharmaceutical grade CZ (% purity 98.1070.86) and PC
(%purity 98.7671.85) were obtained from GlaxoSmithKlinee investigated drugs.
MEKC determination of NSAIDs 55Co. (Cairo, Egypt), DS (% purity 96.4271.78), IP (% purity
97.2370.92), KP (% purity 98.7671.82) and LC (% purity
99.771.25) were from Pharco Pharmaceuticals Co. (Alexandria,
Egypt), MC (% purity 97.0571.12) was from Eva Pharma for
Pharmaceuticals & Medical Appliances S.A.E Co. (Cairo,
Egypt). All investigated drugs were subjected to ofﬁcial
methods [21,22] to determine their purity.
Pharmaceutical preparations containing the studied drugs
were purchased from the local market.
Cetafen tab. IP (200) and PC (325) were obtained from
Queen Pharma International, Cairo, Egypt, Flexofan cap. KP
(50) and CZ (250) from Amirya Pharma. Ind., Alexandria,
Egypt, Ibuﬂex tab. IP (400) and MC (750) from GlobalNap
Pharmaceutical 6 October, Giza, Egypt, Myofen cap. IP (200)
and CZ (250) from Eva Pharma, Cairo, Egypt, Olfen amp. DS
(75) and LC (25) from MUP, Abusultan, Ismailia, Egypt.
SDS was obtained from Sigma-Aldrich, St Louis, USA.
Ultrapure Milli-Q water (Millipore, Bedford, MA, USA)
was used for preparation of running buffers. All chemicals
used for the preparation of buffer electrolytes were of
analytical- reagent grade.
2.3. Preparation of working standard solutions
Accurately weighed 6, 12, 30, 50, 50 and 110 mg of IP, CZ, KP,
DS, LC or MC, respectively were transferred to 10 mL volu-
metric ﬂasks containing 5 mL methanol. The contents of the
ﬂasks were shaken well and completed to the mark with methanol
to obtain the stock standard solutions of the studied drugs.
Further dilutions of the stock solutions with methanol were made
to get working standard solutions in the following concentration
ranges: 0.06–1.8 mg/mL for CZ, 0.27–4.8 mg/mL for DS, 0.03–
0.8 mg/mL for IP, 0.20–2.2 mg/mL for KP, 0.30–4.4 mg/mL for
LC, 1.10–10.1 mg/mL for MC and 0.03–1.0 mg/mL for PC.
2.4. Preparation of synthetic mixture solution
Into 10 mL volumetric ﬂask, known accurate volumes of stock
standard solutions of the seven investigated drugs were mixed
and diluted to contain 0.5 mg/mL of CZ, 4.2 mg/mL of DS,
non- steroidal anti-inﬂammatory drugs (NSAIDs), 0.4 mg/mL
of IP, 0.3 mg/mL of KP, 1.4 mg/mL of LC, 1.5 mg/mL of MC
and 0.64 mg/mL of PC.
2.5. Analysis of dosage forms
2.5.1. Capsules
The contents of 20 Flexofan capsules were accurately weighed,
evacuated, ﬁnely powdered and mixed thoroughly. An accu-
rately weighed amount of mixed powder equivalent to 0.1 mg
KP and 0.5 mg CZ was transferred to 10 mL calibrated ﬂask,
dissolved in about 7 mL methanol (high performance liquid
chromatography grade), sonicated for 10 min, diluted to the
mark with methanol, mixed well and then ﬁltered. The ﬁrst
portion of the ﬁltrate was rejected. The prepared solution was
diluted quantitatively to obtain the required concentration for
the assay.
2.5.2. Tablets
Twenty tablets were accurately weighed, ﬁnely powdered and
mixed thoroughly. Known amount of powdered Cetafentabletss mix equivalent to 0.15 mg IP and 0.24 mg PC was
accurately weighed and treated as capsules to get working
sample solution containing 18.3 mg/mL IP and 29.7 mg/mL PC
after further dilutions. For Ibuﬂex tabletss the same previous
steps were carried out to get working sample solution contain-
ing 18.3 mg/mL IP and 34.3 mg/mL MC.
2.5.3. Ampoules
The contents of ten olfen ampouless were mixed well and
accurately measured volume equivalent to 0.1 mg LC and
0.3 mg DS was transferred to 10 mL calibrated ﬂask, diluted
to the mark with methanol ( high performance liquid chroma-
tography grade ) and further dilutions were done to get working
sample solution containing 45 mg/mL DS and 15 mg/mL LC.3. Results and discussion
In the present work, the seven drugs were separated and
determined by CE (MEKCmode) simultaneously in a laboratory
prepared synthetic mixture and the same method was applied for
separation and determination of ﬁve pharmaceutical binary
mixtures. Three of the drugs belong to NSAIDs (DS, IP and
KP), formulated with four adjuvants (CZ, LC, MC and PC) and
marketed in ﬁve commonly prescribed pharmaceutical dosage
forms. To our knowledge, no CE method has been developed for
the determination of these binary mixtures. The method depends
on the difference in polarity of the investigated compounds
leading to different electrophoretic mobilities and accordingly
different migration times [20].
3.1. Optimization of capillary electrophoretic conditions
All the parameters affecting the efﬁciency of separation through
its effect on electro-osmotic ﬂow were studied and optimized
including buffer system composition (type, pH and ionic
strength), effects of SDS addition and organic modiﬁer addition
as well as analytical voltage.
3.1.1. Buffer system
3.1.1.1. Buffer type. Since the studied drugs are mostly acidic
or neutral, the alkaline pH is preferred for their separation
because the analysis time is relatively shorter than that
obtained at acidic pH, due to the higher electro-osmotic ﬂow
(EOF). In addition at alkaline pH, acidic analytes will migrate
after the EOF. So phosphate and borate buffers were tested at
pH 8. Upon testing the effect of both phosphate and borate
buffers on resolution of the studied drugs, better separation
efﬁciency was obtained with borate buffer. These results agree
well with most CE separations in the literature for analysis of
NSAIDs since they also used borate buffer [17,23].
3.1.1.2. Borate buffer pH and its ionic strength. Borate buffer
solutions ranging from pH 8 to pH 9.5 were investigated.
The pH of the back ground electrolyte (BGE) is known to play
an important role in CE which requires charged analytes, since
it contributes to the degree of dissociation of weak acids or
bases, thus inﬂuencing their effective mobilities [24]. DS, IP
and KP have low pKa values, so they require deprotonation in
alkaline medium to be negatively charged. Varying degrees of
partition of all analytes from SDS micelles at different pH
M.E. El-Kommos et al.56values interpreted the difference in resolution efﬁciency. It was
found that at pH 8 and pH 8.5 most of the peaks were not
resolved and best resolutions were obtained at both pH 9 and
9.5. However, pH 9 was preferred due to shorter analysis time as
illustrated in Fig. 2. Also, the elution order varied at different
pHs due to difference in polarities of the investigated drugs.
Different borate buffer concentrations (5, 10, 20, 40, 60 and
80 mM) were studied at the optimum pH value (pH 9). It is
known that increasing the buffer ionic strength modulates the
EOF and electrophoretic mobility of the analyte. Additionally,
higher concentrations of buffer salts can modulate the effec-
tive charge at the capillary wall and consequently modulate
the interactions between the wall and the solute [24]. It was
found that no separation was achieved upon using 5 or 10 mM
borate buffer and the resolution efﬁciency was gradually
increased with increasing the ionic strength till obtaining the
best resolution at 20 mM concentration then the resolution
started to decrease at higher buffer concentrations. Therefore,
the optimum composition of the buffer was 20 mM ionic
strength of borate buffer at pH 9.0.
3.1.1.3. Surfactant addition. The effect of addition of SDS
(the most commonly used anionic surfactant) to the BGE was
studied. This surfactant is characterized by its high aqueous
solubility, low critical micellar concentration (CMC) (8.1 mM),
small ultraviolet light molar absorptivity, availability and low
cost [25]. It was found that addition of SDS gives great
improvement for both resolution and peak shapes of all analytes.Fig. 2 MEKC separation of (1) Paracetamol (PC), (2) Metho-
carbamol (MC), (3) Ketoprofen (KP), (4) Ibuprofen (IP), (5)
Diclofenac sodium (DS), (6) Chlorzoxazone (CZ) and (7) Lido-
caine hydrochloride (LC) of concentrations 0.64, 1.5, 0.3, 0.4, 4.2,
0.5 and 1.4 mg/mL, respectively, at different borate buffer pH
values; (A) pH 8.00, (B) pH 8.50, (C) pH 9.00, and (D) pH 9.50.Since all investigated analytes exhibited anionic and neutral
characters in alkaline conditions of borate buffer (pH 9),
addition of SDS improved their resolution greatly which
supported the previously mentioned facts.
Different concentrations of SDS were tested including 40, 60,
80, 100 and 120 mM. The best resolution was obtained with
100 mM concentration.
3.1.1.4. Type of organic modiﬁer added and its percentage.
Trials were made to separate the investigated binary mixtures
without addition of organic modiﬁer to the BGE but they
failed, so methanol and acetonitrile were tested in order to
improve the separation and determination efﬁciency. The
organic modiﬁers affect the distribution of the analytes
between aqueous phase and micelles, also it can affect the
charge state of ionizable groups. Best results were obtained
with methanol and this can be explained by the fact that
methanol can decrease the zeta potential and reduce the EOF,
so it increases the separation efﬁciency [2]. The effect of
methanol percentage in the BGE was studied in the range
5–20%. Further increase in methanol concentration was
avoided since it will prolong the migration time and will
broaden the peaks [17] because it decrease EOF. It was
found that upon using 15% methanol in the BGE, all studied
drugs exhibited best resolution efﬁciencies as illustrated in
Fig. 3.Fig. 3 MEKC separation of: (1) paracetamol (PC), (2) Metho-
carbamol (MC), (3) Ketoprofen (KP), (4) Ibuprofen (IP), (5)
Diclofenac sodium (DS), (6) Chlorzoxazone (CZ) and (7) Lido-
caine hydrochloride (LC) of concentrations 0.64, 1.5, 0.3, 0.4, 4.2,
0.5 and 1.4 mg/mL, respectively, using different methanol con-
centrations in the running electrolyte; (A) 5%, (B) 10%, (C) 15%,
and (D) 20%.
MEKC determination of NSAIDs 57It is apparent from the study that 10% and 15% methanol
in the BGE exhibited the best results. However, when 10%
methanol was used, shorter analysis time was obtained
and overlapping between IP and KP occurred. On the other
hand, when using 15% methanol in the BGE all the investi-
gated drugs were well resolved with symmetric and sharp
signals. Therefore, it was selected in the general assay
procedure.
3.1.2. Analytical voltage
Analyses at different potentials (5, 10, 15, 20 and 20 kV) were
carried out to determine the optimum voltage. Upon trying 5
and 10 kV, we got very bad resolution due to overlapped
broad bands for most analytes, while at 15 kV we got the best
resolution. Upon raising the applied voltage to 20 kV, over-
lapping between KP and MC signals occurred. We did not test
voltages higher than 20 kV to avoid generation of joule heat
inside the capillary which adversely affects the peak shapes
and deteriorates the inside capillary wall. However, applica-
tion of 20 kV is valuable only in case of DS–LC binary
mixture where it greatly decreases the separation time. This
can be explained by the increase of EOF at higher voltage [20].
3.2. Suggested explanation for the elution order
It was reported that the majority of drugs are either acidic and/or
basic water-soluble compounds. The bases for separation in free
solution CE relies upon an exploitation of differences between
the analytes’ electrophoretic mobilities, which are related to
solutes, charge and size. Consequently, the separation of many
drugs is possible by free-solution capillary electrophoresis
(FSCE). For example, an acidic drug may be analyzed in its
anionic form at high pH and basic drugs may be tested at low
pH in the cationic form. Zwitterionic drugs (those containing
both acidic and basic groups) may be analyzed at either end of
the pH range. A mixture of neutral drugs would be unresolved
by FSCE. However, ionic, charged micelles can be incorporated
into the electrolyte solution to add a partitioning element to the
separation. This is the basic idea behind MEKC [26]. The seven
studied drugs have different ionization constants affecting their
separation behavior, paracetamol and methocarbamol (pKa 9.5,
14.5, respectively) are zweitter ions and their acidic protons are
ionized in the alkaline medium of borate buffer (pH 9) resulting
in imparting strong negative charge on their molecules under-
going strong repulsion with the negatively charged surface ofTable 1 Summary for the quantitative parameters and statistical
drugs.
Drug Intercept
(a)7SD
Slope
(b)7SD
Linearity range
(mg/mL)
Diclofenac
sodium
126.80070.067 0.19770.001 0.30–4.80
Ibuprofen 72.00070.038 3.61070.003 0.02–0.80
Ketoprofen 1367.40070.007 18.66070.020 0.20–2.20
Chlorzoxazone 544.20070.002 12.51070.001 0.06–1.80
Lidocaine HCl 223.40070.010 0.43770.049 0.30–4.40
Methocarbamol 2668.30070.062 1.01070.001 1.10–10.10
Paracetamol 30.23070.077 0.62270.001 0.03–1.05
nAverage of ﬁve determinations.SDS resulting in their ﬁrst elution, paracetamol ﬁrstly owing to
its smaller molecular weight (151.71 g/mole) then methocarba-
mol of the higher molecular weight (241.2 g/mole), followed by
the three NSAIDs acidic drugs which appeared in the following
sequence; the most acidic one ketoprofen (pKa 4), ibuprofen (pKa
4.4) then diclofenac sodium (pKa 4.1) which has the highest
molecular weight of the three (318.1 g/mole) interpreting its late
appearance after ibuprofen, then coming the zweitter ion
chlorzoxazone (pKa 8.3) which is not greatly affected (weak
ionization for its hydroxyl group) at this alkaline pH owing to
the presence of strong alkaline nucleus (oxazole ring) keeping a
weak basic character for the molecule, ﬁnally coming the basic
drug lidocaine hydrochloride (pKa 7.9 and M. Wt. 251.3 g/mole).
3.3. Analytical method validation
Method validation is the process of making analytical techni-
que performance adequate for its intended use in the future
[27]. A developed analytical method must ensure a minimum
package of validation experiments that are conducted giving
satisfactory results. For an acceptable analytical methodology
and method development, certain method validation steps are
required according to USP 31 NF 26 [22] and ICH guidelines
[28]. The validation parameters tested included: Linearity,
limit of detection (LOD) and limit of quantitation (LOQ),
accuracy, precision, robustness and ruggedness.
3.3.1. Linearity
Under the optimum chromatographic conditions, the relation-
ship between peak areas and concentration was linear and
ranged from 0.02 to 4.80 mg/mL for all the studied drugs,
which permits efﬁcient determination of them in their phar-
maceutical dosage forms especially they have high therapeutic
doses. The intercepts (a), slopes (b), correlation coefﬁcients,
LOD and LOQ are summarized in Table 1.
The LOD for all the studied drugs ranged from 8.2 103
to 0.32 mg/mL and LOQ ranged from 0.02 to 1.1 mg/mL.
These ﬁndings indicate very high sensitivity of the proposed
method as illustrated in Table 1.
3.3.2. Accuracy
Accuracy was determined by comparing measured concentra-
tions of IP, PC, CZ, MC, KP, DS and LC with the actual
values and expressed as percentage. The accuracy was mea-
sured and calculated for each of the studied drugs at threedata using the proposed MEKC method for analysis of studied
Correlation
coefﬁcient (r)
Determination
coefﬁcient (r2)
LOD
(mg/mL)
LOQ
(mg/mL)
0.9998 0.9996 0.10 0.30
0.9998 0.9997 8.20 103 0.02
0.9994 0.9990 0.05 0.20
0.9998 0.9996 0.02 0.06
0.9997 0.9995 0.10 0.30
0.9995 0.9990 0.32 1.10
0.9999 0.9999 0.01 0.03
Table 2 Accuracy and precision of the proposed MEKC method.
Drug Drug conc.
(mg/mL)
Accuracy
(%recovery7SD)
Intra-day precision Inter-day precision
Mean7SD RSD (%) Mean7SD RSD (%)
Chlorzoxazone 0.15 97.6070.82 101.5070.62 0.61 98.5070.88 0.89
0.20 99.1071.06 99.0071.35 1.36 98.8070.93 0.94
0.30 98.5071.87 100.5070.96 0.95 97.3070.62 0.63
Diclofenac sodium 1.00 100.2071.70 98.8071.26 1.27 102.6071.58 1.54
2.00 98.4070.58 99.6070.67 0.67 98.2070.45 0.46
3.00 101.4070.16 101.6070.82 0.81 101.1070.77 0.76
Ibuprofen 0.06 102.7070.38 100.0070.42 0.42 97.8070.86 0.88
0.10 99.3070.96 98.8070.17 0.17 99.9071.74 1.74
0.30 101.4070.16 102.1070.98 0.96 99.6071.35 1.35
Ketoprofen 0.20 98.5071.20 99.7070.20 0.20 97.6071.60 1.60
1.05 101.1070.88 101.7070.84 0.82 97.3070.76 0.78
1.15 100.6070.76 98.7070.66 0.67 98.6070.72 0.73
Lidocaine HCl 0.80 102.8070.56 101.3071.70 0.16 98.7070.33 0.33
1.00 101.3070.72 100.7070.63 0.62 102.3071.21 1.20
2.00 98.7071.48 98.6070.94 0.95 98.2071.60 1.60
Methocarbamol 1.30 101.1071.62 100.5070.97 0.96 98.5071.63 1.65
2.00 99.8070.95 98.7070.51 0.52 101.8070.72 0.70
5.00 97.9070.63 100.1070.26 0.26 98.2070.68 0.70
Paracetamol 0.20 98.4070.24 99.2070.95 0.96 98.1070.38 0.38
0.30 98.8070.72 98.7071.36 1.37 101.3071.90 1.87
0.50 100.5070.59 99.5071.60 1.60 98.0071.41 1.42
nAverage of three determinations.
M.E. El-Kommos et al.58concentration levels covering the linear range. The results are
shown in Table 2 illustrating high accuracy and excellent
recovery percentages ranging from 97.57% to 102.80%.
3.3.3. Precision
Intra-day precision was determined by replicate analysis
(n¼3) of standard solutions at low (0.15 mg/mL), medium
(0.20 mg/mL), and high (0.20 mg/mL) concentration levels
Table 2. The inter-day precision was conducted by repeating
the analysis over a period of three consecutive days. The
overall precision of the method was expressed as relative
standard deviations (RSDs). It was found that RSDs for all
studied drugs were less than 2% indicating good repeatability
and precision.
3.3.4. Robustness
The robustness of an analytical method is deﬁned as a measure
of its capacity to remain unaffected by small but deliberate
variations in method parameters. The most sensitive electro-
phoretic parameters that could affect separation performances
were examined: buffer pH (70.2), buffer ionic strength
(70.2 mM), and organic modiﬁer percent (70.5%). It was
found that minor variations of these variables did not
signiﬁcantly affect the performance of the method as shown
in Table 3. So the method can be considered robust.
3.3.5. Ruggedness
Ruggedness can be deﬁned as the degree of reproducibility of
test results obtained by the analysis of the same samples under
a variety of conditions, and it was achieved in our proposed
method by its application by different analysts during different
days and precise results were obtained. The suggested method
was found to be rugged.Thus, the developed validated MEKC is an accurate,
precise, robust and simple method for the determination of
ﬁve binary mixtures containing some NSAIDs. The method
can be used for the analytical quality control of the dosage
forms which contain these mixtures.
3.4. Application of the developed MEKC method
for pharmaceutical preparations
The proposed method was successfully applied to the assay of
the seven drugs in the ﬁve pharmaceutical binary mixtures.
The proposed method was found to be selective due to
cleanness of the electropherogram of pharmaceutical formula-
tions. The average percentage recoveries of different concen-
trations were based on the average of three replicates
determinations and the results obtained were compared with
reported HPLC methods by means of t- and F- tests at 95%
conﬁdence level for each drug (Table 4). No signiﬁcant
differences were found between the results obtained by the
reported HPLC methods and the proposed method for the
studied pharmaceutical binary mixtures, indicating good
accuracy and precision. Thus the proposed MEKC method
can be used in quality control laboratories for simultaneous
determination of the investigated binary mixtures.4. Conclusion
An MEKC method was developed for the simultaneous
determination of seven drugs and applied for the separation
and determination of ﬁve pharmaceutical binary mixtures
containing three NSAIDs under the same electrophoretic
conditions. The proposed method was validated according to
ICH and USP 31 NF 26 guidelines. The validation study
Table 3 Robustness of the proposed MEKC method for analysis of studied drugs (%recoverya7SD).
Drug Experimental parameters
No variationb Borate buffer pH Ionic strength of borate (mM) Methanol percentage (%)
pH 9.20 pH 8.80 20.20 19.80 15.50 14.50
Lidocaine HCl
Area 98.8070.94 101.6070.52 99.8070.87 98.4071.63 100.6071.05 99.9070.79 98.7071.52
Migration time (min) 99.6070.42 98.1070.62 98.1070.62 102.5070.66 98.7071.24 101.8071.61 100.5071.02
Methocarbamol
Area 101.2071.10 100.4070.23 99.7071.37 100.6571.57 100.6070.15 98.5070.67 100.0070.48
Migration time (min) 100.1070.30 97.8070.69 101.3070.77 98.7070.59 99.5070.67 101.6071.40 97.8070.20
Paracetamol
Area 99.6071.50 98.8070.90 98.7071.36 101.2070.70 98.8070.40 99.5070.93 100.6070.60
Migration time (min) 102.3070.72 101.5070.56 102.4070.62 98.7071.82 97.6070.63 98.5070.86 100.3070.64
Chlorzoxazone
Area 101.2070.82 99.7070.71 98.9070.93 101.1070.45 100.2070.68 97.9070.29 98.1071.47
Migration time (min) 98.7071.42 101.4070.45 98.5071.31 97.9071.72 98.7071.80 101.5070.46 99.8070.89
Diclofenac sodium
Area 101.3070.96 100.2071.26 101.6070.24 98.8070.53 101.7071.27 98.9071.20 99.7070.75
Migration time (min) 101.5070.25 97.8071.11 99.7070.69 99.5071.06 98.2070.23 102.0070.80 98.6070.70
Ibuprofen
Area 99.0071.80 98.9070.97 99.0070.80 100.4070.82 101.6071.36 100.2070.60 98.1071.40
Migration time (min) 102.4072.00 102.5070.38 98.6071.62 97.4070.91 98.3070.55 101.6070.90 98.6071.56
Ketoprofen
Area 98.8071.65 99.5070.53 101.1071.08 100.5070.83 98.7070.70 99.4070.53 100.1070.28
Migration time (min) 101.1071.30 97.8071.70 100.4070.60 98.1070.40 98.5071.10 98.7070.60 101.5070.30
aAverage of three determinations.
bFollowing the general assay procedure conditions.
Table 4 Assay of the studied dosage forms using the proposed and reported procedures.
Dosage form Drug (content; mg) %Recovery7SD (n¼3) F-value t-value
Proposed method Reported method
1-Cetafen tabs PC 325 98.8070.75 98.8070.80 [7] 2.75 1.06
IP 200 102.1070.84 100.8070.74 [7] 6.23 2.10
2-Flexofan caps KP 50 101.3070.96 97.9070.67 [11] 8.24 2.52
CZ 250 97.6071.26 99.3071.05 [11] 3.57 2.26
3-Ibuﬂex tabs IP 450 99.4070.93 98.8071.24 [8] 4.63 1.32
MC 750 101.7071.28 101.2070.57 [8] 3.92 2.63
4-Myofen caps IP 200 101.1070.75 99.6070.98 [5] 13.98 2.20
CZ 250 98.9071.76 101.7071.53 [5] 4.25 1.68
5-Olfen amps DS 75 99.8071.59 101.3071.73 [3] 5.62 2.70
LC 25 102.7070.88 98.1070.67 [3] 7.53 2.35
nAverage of three determinations.
nnTheoretical values of F and t at 95% conﬁdence limit are 19 and 2.92.
nnnReferences [7], [11], [8], [5] and [3] for the reported methods.
MEKC determination of NSAIDs 59showed that the method is simple, accurate, precise, selective
and economic. The method can be applied in quality control
laboratories not only for the investigated binary mixtures but
also for possible future binary mixtures containing the same
components.
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